Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

Published Oct 19, 2020

Keytruda Extends Life for Those Fighting Hodgkin Lymphoma & It’s Now FDA-Approved as Treatment

People with relapsed or treatment-resistant classic Hodgkin Lymphoma now have FDA approval to use Keytruda. The immunotherapy treatment is proven to extend life.

NOW
PLAYING
Comedian Louie Anderson, 68, Reveals Cancer Diagnosis and Hospitalization
NOW
PLAYING
CAR T-Cell Therapy: A Promising New Approach to Relapsed Multiple Myeloma
NOW
PLAYING
How Does Induction Therapy for Multiple Myeloma Work?
NOW
PLAYING
Mark Cuban's Shocking Purchase of Texas "Ghost Town" Was Actually To Help a Friend Who Passed From Leukemia
NOW
PLAYING
Cancer Patients Need to Understand What's At Stake in The Build Back Better Legislation
NOW
PLAYING
23-Year-Old Chloe Girardier Was Denied an In-Person Doctor's Visit; She Fought for Herself to be Seen, and Was Diagnosed with Hodgkin Lymphom

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.